from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3378c/-

LFCtreatmentdescriptionclass of inhibitor

-0.528

Amikacinug/mL Amikacintranslation

1.242

Cap5-10ug/mL Capreomycintranslation

0.559

Rox10-50 ug/mL Roxithromycintranslation

1.042

SM2-5 ug/mL Streptomycintranslation

-0.646

Tet5-10 ug/mL Tetracyclinetranslation

-0.565

Rif0.2-5ug/mL Rifampicintranscription

0.043

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.317

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.026

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.377

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.515

Clofazimine10-13 ug/mL Clofaziminerespiration

1.007

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.078

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.356

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.785

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.107

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.140

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.173

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.027

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.138

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.450

KCN5-20 ug/mL Potassium cyaniderespiration

0.503

NaN30.2-2 mM Sodium aziderespiration

0.421

Nigericin50 uM Nigericinrespiration

-0.716

TRC10-150 ug/mL Triclosanrespiration

-0.912

TRZ10-25 ug/mL Thioridazinerespiration

-0.973

Valinomycin0.5-10 uM Valinomycinrespiration

0.385

ZnSO42 mM ZnSO4respiration

-0.436

menadione6-10 ug/mL Menadionerespiration

-0.190

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.379

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.288

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.264

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.076

NRP_1Non-replicating persistence stage 1dosRassociated

0.961

Amp0.2mg/mL AmpicillincellWall

0.218

Cephalexin20-100 ug/mL CephalexincellWall

0.164

Cerulenin0.32-5 ug/mL CerulenincellWall

0.715

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.372

EMB10-20 ug/mL EthambutolcellWall

0.798

Eta12-40 ug/mL EthionamidecellWall

0.527

INH0.2-0.4 ug/mL IsoniazidcellWall

0.570

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.150

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.811

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.330

BZA0.12 mg/mL BenzamidearomaticAmides

0.012

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.176

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.462

H2O24 mM hydrogen peroxideDNAdamaging

1.780

Levo10 ug/mL LevofloxacinDNAdamaging

0.236

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.089

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.626

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.423

UVUV-irradiationDNAdamaging

-1.796

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.002

Antimycin12.5-50 ug/mL Antimycin A?

0.548

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.635

PA_110-50 ug/mL Antitubercular compound PA-1?

0.519

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.855

PA8240.2-2 ug/mL PA-824?

-0.154

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.189

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.373

Verapamil50 uM Verapamil?

0.000

mercaptoethanol2 mM 2-Mercaptoethanol?

0.036

methoxatin10-20 ug/mL Methoxatin?